Latest Clostridium Stories
A synthetic mixture of intestinal bacteria could one day replace stool transplants as a treatment for Clostridium difficile (C. difficile) A synthetic mixture of intestinal bacteria could one day replace stool transplants as a treatment for Clostridium difficile (C. difficile). C. difficile is a toxin-producing bacteria that can overpopulate the colon when antibiotics eradicate other, naturally protective bacteria living there. "A synthetic stool transplant has a lot of potential...
MADISON, N.J. and CYPRESS, Calif., April 11, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its Simplexa C. difficile Universal Direct Test on the 3M(TM) Integrated Cycler. The test, from the company's Focus Diagnostics business, is intended to aid in the diagnosis of Clostridium difficile-associated...
STAINES, UK, March 31, 2012 /PRNewswire/ -- Clostridium difficile infection (CDI), a potentially fatal disease, is one of the most common healthcare acquired infections in Europe[1] New data presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) demonstrate that in cancer patients with CDI, DIFICLIR( fidaxomicin) may offer significant benefits in terms of clinical cure*, recurrence[#] and sustained...
SAN DIEGO and TOKYO, March 29, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) and Tokyo-based Astellas Pharma Inc. (Tokyo: 4503) announced today the execution of an exclusive collaboration and license agreement to develop and commercialize fidaxomicin tablets in Japan for the treatment of Clostridium difficile Infection (CDI). (Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO) In return for the exclusive license to fidaxomicin in Japan, Optimer is...
SAN DIEGO, March 28, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Company will present at the 11th Annual Needham Healthcare Conference on Tuesday, April 3 at 3:20 p.m. Eastern Time in New York, NY. (Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO) A live audio webcast of the presentation will be accessible on the Investors page of the Company's website at www.optimerpharma.com. Replays of the presentation will be...
C. difficile and norovirus are the leading causes The number of people who died from gastroenteritis (inflammation of the stomach and intestines that causes vomiting and diarrhea) more than doubled from 1999 to 2007. The findings of this study will be presented today at the International Conference on Emerging Infectious Diseases in Atlanta. CDC scientists used data from the National Center for Health Statistics to identify gastroenteritis-associated deaths that occurred from 1999 to...
C. difficile and norovirus are the leading causes ATLANTA, March 14, 2012 /PRNewswire-USNewswire/ -- The number of people who died from gastroenteritis (inflammation of the stomach and intestines that causes vomiting and diarrhea) more than doubled from 1999 to 2007, according to a study by the Centers for Disease Control and Prevention. The findings will be presented today at the International Conference on Emerging Infectious Diseases in Atlanta. CDC scientists used data from...
VOORHEES, N.J., Dec. 20, 2011 /PRNewswire/ -- Rates of Clostridium difficile Infection (CDI) have been on the rise in recent years and this diagnosis can result in significant costs for both individuals and the healthcare system as a whole. Given the recent updated guidelines for CDI, combined with several new agents emerging for this disease, it is critical for healthcare professionals to be aware of the most current research and recommendations for the management of CDI. To...
The Science Magazine EurekaMag.com publishes articles in all areas of biological science. The latest articles cover Abalone which are small to very large edible sea snails, the Krebs Cycle which is a cycle of chemical reactions used by all aerobic living organisms to generate energy, and Clostridium which is a genus of bacteria with multiple bio-industrial uses. Mannheim, Germany (PRWEB) December 09, 2011 The Biology Magazine EurekaMag.com publishes articles in all areas of biological...
Mouse Model Study Reinforces Positive Effects of Probiotics for the Immune System Cleveland, OH (PRWEB) December 01, 2011 Researchers from Ganeden Biotech and Penn State College of Medicine have found that GanedenBC30®, a probiotic (beneficial bacteria), has prolonged the survival of, and improved the stool consistency of, C. diff-induced colitis in mice. The study, “Bacillus Coagulams GBI-30 (BC30) improves indices of Clostridium difficile-induced colitis in mice†was...
Latest Clostridium Reference Libraries
Clostridium botulinum is a gram-positive, rod-shaped bacterium that produces neurotoxins, known as botulinum neurotoxins types A-G, that cause the flaccid muscular paralysis seen in botulism. It is the main paralytic agent in botox and is commonly found in soil. It is also an obligate anaerobe, meaning oxygen is poisonous to the cells. Superoxide dismutase helps C. botulinum tolerate traces of oxygen. It was first recognized and isolated in 1895 by Emile van Ermengem. Subsequent outbreaks...
